JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Agachi, Svetlana | |
| dc.contributor.author | Groppa, Liliana | |
| dc.contributor.author | Rotaru, Larisa | |
| dc.contributor.author | Corotaş, Valeriu | |
| dc.contributor.author | Bonari, Elena | |
| dc.date.accessioned | 2019-06-14T07:59:06Z | |
| dc.date.available | 2019-06-14T07:59:06Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | AGACHI, Svetlana, GROPPA, Liliana, ROTARU, Larisa, COROTAŞ, Valeriu, BONARI, Elena. Influenţa statinelor asupra modificărilor cutanate la pacienţii cu sclerodermie sistemică. In: Sănătate Publică, Economie şi Management în Medicină. 2016, nr. 2(66), p. 109. ISSN 1729-8687. | ro |
| dc.identifier.issn | 1729-8687 | |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/1545 | |
| dc.identifier.uri | http://revistaspemm.md/wp-content/uploads/2019/05/cm2_66_2016cg.pdf | |
| dc.description | USMF Nicolae Testemițanu, Spitalul Clinic Municipal Sfânta Treime, Conferinţa consacrată aniversării celor 40 de ani de la fondarea SCM Sfânta Treime 17 iunie 2016 Chișinău, Republica Moldova | en_US |
| dc.description.abstract | Statins are included in the complex treatment of patients with systemic sclerosis who suffer from digital ulcers. Recent studies have proved the beneficial impact of statins in both hepatic and cardiac fibrosis. We studed the effect of atorvastatin on skin changes in 60 patients with systemic sclerosis and cocluded that atorvastatin can be included in the complex treatment of patients with systemic sclerosis not only for treating vasculopathy, as well as for the improvement of skin indurative changes. | en_US |
| dc.description.abstract | Статины включены в комплексное лечение больных системной склеродермией, страдающих дигитальными язвами. Недавние исследования доказали благотворное влияние статинов на фиброз печени и сердца. Данное исследование выяснило эффект аторвастатина на изменения со стороны кожи у 60 пациентов с системной склеродермией и позволило сделать вывод, что аторвастатин может быть включен в комплексное лечение больных с системной склеродермией не только для лечения васкулопатии, а также для улучшения индуративных изменений кожи. | ru |
| dc.language.iso | ro | en_US |
| dc.publisher | Asociația Obștească ”Economie, Management și Psihologie în Medicină” din Republica Moldova | en_US |
| dc.subject | systemic sclerosis | en_US |
| dc.subject | atorvastatin | en_US |
| dc.subject | modified Rodnan score | en_US |
| dc.subject.mesh | Scleroderma, Systemic--physiopathology | en_US |
| dc.subject.mesh | Scleroderma, Systemic--drug therapy | en_US |
| dc.subject.mesh | Atorvastatin--therapeutic use | en_US |
| dc.title | Influenţa statinelor asupra modificărilor cutanate la pacienţii cu sclerodermie sistemică | ro |
| dc.title.alternative | Influence of atorvastatin of the skin changes of systemic sclerosis | en_US |
| dc.title.alternative | Влияние аторвастатина на кожные изменения у больных системной склеродермией | ru |
| dc.type | Article | en_US |
Files in this item
This item appears in the following Collection(s)
-
Sănătate Publică, Economie şi Management în Medicină Nr. 2 (66) / 2016
Materialele Conferinţei consacrate aniversării celor 40 de ani de la fondarea SCM Sfânta Treime 17 iunie 2016 Chișinău, Republica Moldova